There are 2867 resources available
652O - Randomized phase III VANCE study: Gemcitabine and carboplatin (GC) followed by Epstein Barr virus-specific autologous cytotoxic T lymphocytes (EBV-CTL) versus the same chemotherapy as first-line treatment for advanced nasopharyngeal carcinoma (NPC)
Presenter: Han Chong Toh
Session: Proffered Paper session: Head & neck cancer
Resources:
Abstract
Slides
Webcast
318MO - Circulating tumour DNA (ctDNA) dynamics, CEA and sites of recurrence for the randomised DYNAMIC study: Adjuvant chemotherapy (ACT) guided by ctDNA analysis in stage II colon cancer (CC)
Presenter: Jeanne Tie
Session: Mini Oral session: GI, lower digestive
Resources:
Abstract
Slides
Webcast
LBA71 - First-line nivolumab (NIVO) plus ipilimumab (IPI) vs chemotherapy (chemo) in patients (pts) with unresectable malignant pleural mesothelioma (uMPM): 4-year update from CheckMate 743
Presenter: Gerard Zalcman
Session: Mini Oral session: Non-metastatic NSCLC and other thoracic malignancies
Resources:
Abstract
Slides
Webcast
627MO - Orelabrutinib plus RCHOP for previously untreated non-germinal center b cell-like (GCB) diffuse large b cell lymphoma (DLBCL) patients with extranodal disease
Presenter: Mingyue Wang
Session: Mini Oral session: Haematological malignancies
Resources:
Abstract
Slides
Webcast
1491MO - New benchmarks for designing clinical trials in advanced or metastatic liposarcoma (LPS) or synovial sarcoma (SS): An EORTC soft tissue and bone sarcoma group meta-analysis
Presenter: Georgios Kantidakis
Session: Mini Oral session: Sarcoma
Resources:
Abstract
Slides
Webcast
1448O - Phase II KEYNOTE-B61 study of pembrolizumab (Pembro) + lenvatinib (Lenva) as first-line treatment for non-clear cell renal cell carcinoma (nccRCC)
Presenter: Laurence Albiges
Session: Proffered Paper session 2: GU tumours, non-prostate
Resources:
Abstract
Slides
Webcast
653O - Neoadjuvant nivolumab (N) before chemoradiation (CRT) in high-risk HPV driven oropharynx cancer (OPC) - IMMUNEBOOST-HPV: A multicenter randomized phase II trial
Presenter: Haitham Mirghani
Session: Proffered Paper session: Head & neck cancer
Resources:
Abstract
Slides
Webcast
319MO - Real-world monitoring of circulating tumor DNA reliably predicts cancer recurrence in patients with resected stages I-III colorectal cancer
Presenter: Stacey Cohen
Session: Mini Oral session: GI, lower digestive
Resources:
Abstract
Slides
Webcast
931MO - Final overall survival analysis of phase III study of pemetrexed/cisplatin versus vinorelbine/cisplatin for completely resected non-squamous non-small cell lung cancer: The JIPANG Study
Presenter: Kiyotaka Yoh
Session: Mini Oral session: Non-metastatic NSCLC and other thoracic malignancies
Resources:
Abstract
Slides
Webcast
Discussion
Presenter: All Speakers
Session: Creating a new stage between early and metastatic cancers: Illustration with lung cancers
Resources:
Webcast